Chemocentryx (CCXI) Reports Q4 EPS of 61c, Revs Double
Tweet Send to a FriendGet Alerts CCXI Hot Sheet
Trade CCXI Now!
Chemocentryx (NASDAQ: CCXI) reported Q4 EPS of $0.61, versus $0.17 reported last year. Revenue for the quarter came in at $26.1 thousand, versus $13.1 million reported last year.
For earnings history and earnings-related data on Chemocentryx (CCXI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Chemocentryx (CCXI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- Tough Print Market Leads Tribune to Lower Profits in FY12 (NWSA)
- Rentrak Corp (RENT) Misses Q4 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
